KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) EBITDA Margin (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed EBITDA Margin for 17 consecutive years, with 81.68% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin fell 265.0% to 81.68% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 42.39% through Dec 2025, up 140.0% year-over-year, with the annual reading at 42.39% for FY2025, 140.0% up from the prior year.
  • EBITDA Margin hit 81.68% in Q4 2025 for Johnson & Johnson, up from 29.31% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 84.33% in Q4 2024 to a low of 18.3% in Q1 2021.
  • Historically, EBITDA Margin has averaged 32.51% across 5 years, with a median of 27.5% in 2023.
  • Biggest five-year swings in EBITDA Margin: crashed -2832bps in 2023 and later surged 6446bps in 2024.
  • Year by year, EBITDA Margin stood at 28.31% in 2021, then decreased by -6bps to 26.5% in 2022, then fell by -25bps to 19.87% in 2023, then skyrocketed by 324bps to 84.33% in 2024, then decreased by -3bps to 81.68% in 2025.
  • Business Quant data shows EBITDA Margin for JNJ at 81.68% in Q4 2025, 29.31% in Q3 2025, and 27.99% in Q2 2025.